Andrew Knudten, Advanced Medicine Partners CEO

Jaguar Gene Ther­a­py spins out man­u­fac­tur­ing with Deer­field, ARCH sup­port

Jaguar Gene Ther­a­py will spin out its chem­istry, man­u­fac­tur­ing and con­trols (CMC) op­er­a­tions and cre­ate a sep­a­rate com­pa­ny called Ad­vanced Med­i­cine Part­ners, with the sup­port of Deer­field, ARCH Ven­ture Part­ners, Nolan Cap­i­tal and oth­ers, it said Wednes­day.

The same in­vestors have backed Jaguar, a pre­clin­i­cal gene ther­a­py biotech based in the Chica­go sub­urbs that was formed by AveX­is vet­er­ans hop­ing to re­peat their Zol­gens­ma suc­cess. Ad­vanced Med­i­cine Part­ners de­clined to dis­close how much fi­nan­cial sup­port it is re­ceiv­ing from the in­vestors. ARCH has backed oth­er man­u­fac­tur­ers like Na­tion­al Re­silience.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.